IN2012DN04868A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN04868A IN2012DN04868A IN4868DEN2012A IN2012DN04868A IN 2012DN04868 A IN2012DN04868 A IN 2012DN04868A IN 4868DEN2012 A IN4868DEN2012 A IN 4868DEN2012A IN 2012DN04868 A IN2012DN04868 A IN 2012DN04868A
- Authority
- IN
- India
- Prior art keywords
- compounds
- compound
- formula
- methods
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009101992592A CN102070618B (zh) | 2009-11-23 | 2009-11-23 | 一种化合物及其晶体 |
| PCT/CN2010/078997 WO2011060746A1 (en) | 2009-11-23 | 2010-11-23 | Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN04868A true IN2012DN04868A (uk) | 2015-09-25 |
Family
ID=44029398
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN4868DEN2012 IN2012DN04868A (uk) | 2009-11-23 | 2010-11-23 |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US8658658B2 (uk) |
| EP (1) | EP2504331B1 (uk) |
| JP (1) | JP5758399B2 (uk) |
| KR (1) | KR101513784B1 (uk) |
| CN (2) | CN102070618B (uk) |
| AU (1) | AU2010321366B2 (uk) |
| BR (1) | BR112012012138B1 (uk) |
| CA (1) | CA2781066C (uk) |
| DK (1) | DK2504331T3 (uk) |
| ES (1) | ES2529105T3 (uk) |
| IN (1) | IN2012DN04868A (uk) |
| MX (1) | MX2012005926A (uk) |
| MY (1) | MY161749A (uk) |
| NZ (1) | NZ600266A (uk) |
| PL (1) | PL2504331T3 (uk) |
| PT (1) | PT2504331E (uk) |
| RU (1) | RU2507203C1 (uk) |
| WO (1) | WO2011060746A1 (uk) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102070618B (zh) | 2009-11-23 | 2013-08-21 | 和记黄埔医药（上海）有限公司 | 一种化合物及其晶体 |
| NZ728102A (en) * | 2014-06-19 | 2018-04-27 | Merial Inc | Parasiticidal compositions comprising indole derivatives, methods and uses thereof |
| CN105985326B (zh) * | 2015-02-16 | 2020-04-14 | 上海宣创生物科技有限公司 | 嘧啶衍生物晶型ⅲ及其制备方法和用途 |
| WO2016187767A1 (en) * | 2015-05-25 | 2016-12-01 | Hutchison Medipharma Limited | Pharmaceutical compositions and use thereof |
| JP7308145B2 (ja) * | 2016-11-18 | 2023-07-13 | ハッチソン メディファーマ リミテッド | 固形腫瘍を治療するための医薬組成物 |
| JP2020164434A (ja) * | 2019-03-28 | 2020-10-08 | 上野製薬株式会社 | ２，６−ナフタレンビス（２−オキサゾリン）の製造方法 |
| TW202143969A (zh) * | 2020-03-09 | 2021-12-01 | 大陸商和記黃埔醫藥（上海）有限公司 | 抗ｐｄ－１抗體和多受體酪胺酸激酶抑制劑的藥物組合及其使用方法 |
| US20240043409A1 (en) * | 2021-04-12 | 2024-02-08 | Mitoimmune Therapeutics Inc. | Crystalline forms of 5-[(1,1-dioxido-4-thiomorpholinyl)methyl]-2-phenyl-n-(tetrahydro-2h-pyran-4-yl)-1h-indol-7-amine |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005095357A2 (en) * | 2004-03-30 | 2005-10-13 | Taisho Pharmaceutical Co., Ltd. | Pyrimidine derivatives and methods of treatment related to the use thereof |
| EP1934200A1 (en) | 2005-09-15 | 2008-06-25 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
| EP2154967B9 (en) * | 2007-04-16 | 2014-07-23 | Hutchison Medipharma Enterprises Limited | Pyrimidine derivatives |
| CN101289444B (zh) * | 2007-04-16 | 2012-01-04 | 和记黄埔医药（上海）有限公司 | 一种嘧啶衍生物及其医药用途 |
| TW201008933A (en) * | 2008-08-29 | 2010-03-01 | Hutchison Medipharma Entpr Ltd | Pyrimidine compounds |
| CN102070618B (zh) * | 2009-11-23 | 2013-08-21 | 和记黄埔医药（上海）有限公司 | 一种化合物及其晶体 |
-
2009
- 2009-11-23 CN CN2009101992592A patent/CN102070618B/zh active Active
-
2010
- 2010-11-23 DK DK10831161.4T patent/DK2504331T3/en active
- 2010-11-23 RU RU2012126112/04A patent/RU2507203C1/ru active
- 2010-11-23 WO PCT/CN2010/078997 patent/WO2011060746A1/en active Application Filing
- 2010-11-23 KR KR1020127015836A patent/KR101513784B1/ko active IP Right Grant
- 2010-11-23 IN IN4868DEN2012 patent/IN2012DN04868A/en unknown
- 2010-11-23 AU AU2010321366A patent/AU2010321366B2/en active Active
- 2010-11-23 CN CN201080052921.2A patent/CN102648194B/zh active Active
- 2010-11-23 EP EP10831161.4A patent/EP2504331B1/en active Active
- 2010-11-23 ES ES10831161.4T patent/ES2529105T3/es active Active
- 2010-11-23 PT PT108311614T patent/PT2504331E/pt unknown
- 2010-11-23 PL PL10831161T patent/PL2504331T3/pl unknown
- 2010-11-23 NZ NZ600266A patent/NZ600266A/en unknown
- 2010-11-23 CA CA2781066A patent/CA2781066C/en active Active
- 2010-11-23 MX MX2012005926A patent/MX2012005926A/es active IP Right Grant
- 2010-11-23 MY MYPI2012002250A patent/MY161749A/en unknown
- 2010-11-23 BR BR112012012138-3A patent/BR112012012138B1/pt active IP Right Grant
- 2010-11-23 US US13/510,249 patent/US8658658B2/en active Active
- 2010-11-23 JP JP2012539175A patent/JP5758399B2/ja active Active
-
2013
- 2013-12-12 US US14/104,954 patent/US8946249B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| PL2504331T3 (pl) | 2015-04-30 |
| CA2781066A1 (en) | 2011-05-26 |
| CA2781066C (en) | 2014-09-16 |
| ES2529105T3 (es) | 2015-02-16 |
| US8658658B2 (en) | 2014-02-25 |
| JP2013511475A (ja) | 2013-04-04 |
| US8946249B2 (en) | 2015-02-03 |
| AU2010321366A8 (en) | 2012-07-05 |
| RU2012126112A (ru) | 2013-12-27 |
| PT2504331E (pt) | 2015-02-20 |
| KR101513784B1 (ko) | 2015-04-20 |
| DK2504331T3 (en) | 2014-12-08 |
| EP2504331B1 (en) | 2014-11-12 |
| JP5758399B2 (ja) | 2015-08-05 |
| RU2507203C1 (ru) | 2014-02-20 |
| WO2011060746A1 (en) | 2011-05-26 |
| BR112012012138B1 (pt) | 2023-02-07 |
| MY161749A (en) | 2017-05-15 |
| EP2504331A1 (en) | 2012-10-03 |
| CN102070618B (zh) | 2013-08-21 |
| AU2010321366A1 (en) | 2012-06-14 |
| BR112012012138A2 (pt) | 2017-03-07 |
| CN102648194A (zh) | 2012-08-22 |
| MX2012005926A (es) | 2012-11-23 |
| US20120270889A1 (en) | 2012-10-25 |
| CN102070618A (zh) | 2011-05-25 |
| KR20120097526A (ko) | 2012-09-04 |
| CN102648194B (zh) | 2014-10-29 |
| US20140200232A1 (en) | 2014-07-17 |
| EP2504331A4 (en) | 2013-04-17 |
| AU2010321366B2 (en) | 2014-07-24 |
| NZ600266A (en) | 2014-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX336071B (es) | Formulaciones intravenosas de antagonistas de neurocinina 1. | |
| IN2012DN04868A (uk) | ||
| UA105229C2 (uk) | Фармацевтичний склад | |
| MY187718A (en) | Pharmaceutical formulations | |
| MY193277A (en) | Certain amino-pyrimidines, compositions thereof, and methods for their use | |
| MX2013003019A (es) | Compuestos de azabenzotiazol, composiciones y metodos de uso. | |
| TN2012000152A1 (en) | Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes | |
| TN2012000248A1 (en) | Novel spiropiperidine compounds | |
| EP2590655A4 (en) | COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT | |
| IN2012DN03182A (uk) | ||
| MX340360B (es) | Formulaciones farmaceuticas que comprenden derivados de nitrocatecol y metodos para hacer las mismas. | |
| WO2010128050A3 (en) | Dihydroorotate - dehydrogenasee inhibitors as virostatic compounds | |
| MX2013010511A (es) | Inhibidores triciclicos de girasa. | |
| WO2012015681A3 (en) | Drug-ligand conjugates, synthesis thereof, and intermediates thereto | |
| WO2012135615A3 (en) | Enopeptins, uses thereof, and methods of synthesis thereto | |
| MY160392A (en) | Triptolide prodrugs | |
| MX2013011926A (es) | Derivados de glicosido y usos de los mismos. | |
| WO2010123545A3 (en) | Angiogenesis inhibitors | |
| IN2012DN01292A (uk) | ||
| TN2012000105A1 (en) | Spirolactam derivatives and uses of same | |
| MX2013009386A (es) | Nuevos compuestos de azaespirodecanona. | |
| WO2012015687A3 (en) | Drug-ligand conjugates, synthesis thereof, and intermediates thereto | |
| WO2010146595A3 (en) | Novel polymorphs of flibanserin hydrochloride | |
| GEP20156269B (en) | New secondary 8-hydroxyquinoline-7- carboxamide derivatives | |
| WO2011125006A3 (en) | Sultam compounds |